telogen effluvium
telogen effluvium
Explore linked clinical trials. Standard reference: MONDO:00021533 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gut Microbiota and Trichoscopic Changes in Women With Telogen Effluvium on a Multifactorial Drinkable Nutraceutical: A Retrospective Observational Study | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder, telogen effluvium | Not yet recruiting | Not stated | 2026-10-09 | NCT07869199 | |
| Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists | telogen effluvium | Recruiting | Not applicable | 2026-10-06 | NCT07484061 | |
| Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth | Alopecia, Male Pattern, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder, telogen effluvium | Not yet recruiting | Phase 2 / Phase 3 | 2026-04-13 | NCT06648850 |